Phosphoglycolate synthesis by human erythrocyte pyruvate kinase. 1987

H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko

R2-type pyruvate kinase purified monogeneously from human red cells catalyzes the phosphorylation of glycolate (glycolate kinase). Maximum activation of glycolate kinase was observed at 100 microM fructose-1,6-bisphosphate (Fru-1,6-P2) and at 2 mM glucose-1,6-bisphosphate (Glc-1,6-P2). The Km for ATP was 1.1 mM in the absence of Fru-1,6-P2 and 1.5 mM in the presence of 1 mM Fru-1,6-P2. The Km for glycolate was 20 mM in the absence of Fru-1,6-P2 and 5 mM in the presence of 1.0 mM Fru-1,6-P2. The optimum pH was over 10.5. At the physiological concentrations of Fru-1,6-P2, Glc-1,6-P2 and ATP, the glycolate kinase activity is too low to maintain the reported level of phosphoglycolate (approx. 2-5 microM). It is demonstrated that phosphorylation of glycolate by R2-type pyruvate kinase which is predominant in mature red cells plays no physiological role. The questions whether an unknown pathway for phosphoglycolate synthesis exists or whether there is actually phosphoglycolate in red cells are raised.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011770 Pyruvate Kinase ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40. L-Type Pyruvate Kinase,M-Type Pyruvate Kinase,M1-Type Pyruvate Kinase,M2-Type Pyruvate Kinase,Pyruvate Kinase L,R-Type Pyruvate Kinase,L Type Pyruvate Kinase,M Type Pyruvate Kinase,M1 Type Pyruvate Kinase,M2 Type Pyruvate Kinase,Pyruvate Kinase, L-Type,Pyruvate Kinase, M-Type,Pyruvate Kinase, M1-Type,Pyruvate Kinase, M2-Type,Pyruvate Kinase, R-Type,R Type Pyruvate Kinase
D004163 Diphosphoglyceric Acids Glyceric acids where two of the hydroxyl groups have been replaced by phosphates. Bisphosphoglycerates,Acids, Diphosphoglyceric
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005635 Fructosediphosphates Diphosphoric acid esters of fructose. The fructose-1,6- diphosphate isomer is most prevalent. It is an important intermediate in the glycolysis process.
D006016 Glycolates Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon. 2-Hydroxyacetates,Glycolate Ethers,Hydroxyacetate Ethers,Hydroxyacetates,Hydroxyacetic Acids,2 Hydroxyacetates,Acids, Hydroxyacetic,Ethers, Glycolate,Ethers, Hydroxyacetate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
January 1975, Methods in enzymology,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
September 1971, Life sciences. Pt. 2: Biochemistry, general and molecular biology,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
November 1979, Biochemical and biophysical research communications,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
November 1972, The Journal of biological chemistry,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
January 1967, Biochimica et biophysica acta,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
July 1977, Biochemical and biophysical research communications,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
January 2012, Genes and immunity,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
April 1984, Archives of biochemistry and biophysics,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
January 1982, The International journal of biochemistry,
H Sasaki, and S Fujii, and Y Yoshizaki, and K Nakashima, and T Kaneko
April 1976, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!